Posted on August 27, 2013 by Sitemaster
There is no broad agreement agreement (yet) across the prostate cancer community about acceptable “standard” criteria for eligibility for active surveillance as a form of first-line management of low-risk prostate cancer. On the other hand, there are two well-characterized and relatively broadly applied sets of criteria: … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: active surveillance, criteria, Epstein, Klotz | 4 Comments »
Posted on August 19, 2008 by Sitemaster
Recent publications reported on today include:
- Demonstration of the validity of the Epstein criteria in defining pathologically insignificant prostate cancer
- A review of the value of sildenafil (Viagra) and similar products in treatment of erectile dysfunction among prostate cancer patients
- A review of the significance of “gene fusion” and its relevance in prostate cancer … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: cancer, criteria, Epstein, fusion, gene, inhibitors, insignificant, news, PDE5, prostate, update | 4 Comments »
